MIRAE ASSET SECURITIES (USA) INC.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

MIRAE ASSET SECURITIES (USA) INC.’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.8M	Hold	100,000	–	–	0.47%	45
2025 Q4	$12.2M	Sell	100,000 -1,400,000	-93%	-$161M	0.34%	67
2025 Q3	$150M	Hold	1,500,000	–	–	4.59%	4
2025 Q2	$124M	Hold	1,500,000	–	–	3.81%	6
2025 Q1	$122M	Hold	1,500,000	–	–	3.35%	3
2024 Q4	$135M	Buy	1,500,000 +600,000	+67%	+$58.1M	4.07%	4
2024 Q3	$88.9M	Buy	900,000 +300,000	+50%	+$29.5M	3.58%	5
2024 Q2	$55.6M	Buy	+600,000	New	+$53.8M	2.63%	7

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC.'s XBI Position: Q1 2026 in Review

MIRAE ASSET SECURITIES (USA) INC. held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 100,000 shares worth $12.8M. The position accounts for 0.47% of the portfolio, ranked #45.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in XBI in Q2 2024 and has held it in 8 quarters since. The position peaked at $150M in Q3 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

MIRAE ASSET SECURITIES (USA) INC. held 100,000 shares of State Street SPDR S&P Biotech ETF worth $12.8M as of Q1 2026.
MIRAE ASSET SECURITIES (USA) INC. left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.47% of MIRAE ASSET SECURITIES (USA) INC.'s portfolio in Q1 2026, its #45 holding.
MIRAE ASSET SECURITIES (USA) INC. first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 8 quarters since.
MIRAE ASSET SECURITIES (USA) INC.'s State Street SPDR S&P Biotech ETF position peaked at $150M in Q3 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q1 2026, filed 29 Apr 2026.